Crossmark

PROMs following breast-conserving therapy for breast cancer: results from a prospective longitudinal monocentric study

Crossref DOI link: https://doi.org/10.1007/s00520-019-04698-0

Published Online: 2019-02-21

Published Print: 2019-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kindts, I. https://orcid.org/0000-0002-6570-141X
Laenen, A.

van den Akker, M.

Weltens, C.
Funding

Funding for this research was provided by:

Kom op tegen Kanker
License Information

Text and Data Mining valid from 2019-02-21
More Information

Article History

Received: 17 May 2018

Accepted: 11 February 2019

First Online: 21 February 2019

Compliance with ethical standards

: Informed consent was obtained. The study was approved by the Clinical Trial Centre and the Ethical Committee of our institution.

: The authors declare that they have no conflict of interest.